BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3997513)

  • 1. [Congenital ichthyosiforme erythroderma, pregnancy under aromatic retinoid treatment].
    Jäger K; Schiller F; Stech P
    Hautarzt; 1985 Mar; 36(3):150-3. PubMed ID: 3997513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of congenital erythroderma ichthyosiforme in mother and son with the oral aromatic retinoid Ro 10-9359. The need for maintenance therapy].
    Mashkilleysson AL; Mashkilleysson NA
    Z Hautkr; 1983 Aug; 58(15):1127-9. PubMed ID: 6415945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oral treatment of two pronounced ichthyotic conditions: lamellar ichthyosis and epidermolytic hyperkeratosis with the aromatic retinoid, Tigason (RO 10-9359).
    El-Ramly M; Zachariae H
    Acta Derm Venereol; 1983; 63(5):452-6. PubMed ID: 6197852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral treatment of lamellar ichthyosis (non-bullous congenital ichthyosiform erythroderma) with an aromatic retinoid (author's transl)].
    Frenk E
    Dermatologica; 1981; 162(2):91-103. PubMed ID: 7018943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Teratogenic effects of etretinate in humans].
    Happle R; Traupe H; Bounameaux Y; Fisch T
    Dtsch Med Wochenschr; 1984 Sep; 109(39):1476-80. PubMed ID: 6479047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
    Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
    Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
    Jagell S; Lidén S
    Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
    Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H; Esca SA; Holubar K
    Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone changes in long-term therapy with etretinate (Tigason)].
    Haustein UF; Heilmann S
    Z Hautkr; 1987 Mar; 62(5):395-6, 399-400. PubMed ID: 3590912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disabling errors of skin keratinization. Ichthyosiform erythrodermas and the 'half-baby syndrome' treated with an aromatic retinoid.
    Findlay GH
    S Afr Med J; 1981 May; 59(20):717-20. PubMed ID: 7013111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital psoriasiform erythroderma with bullous eruptions].
    Rocha MM; Silva LG
    Med Cutan Ibero Lat Am; 1976; 4(3):153-8. PubMed ID: 790053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bullous congenital ichthyosiform erythroderma in a mother and son].
    Simoni S; Romano C; Bilenchi R; Alessandrini C; Fimiani M
    G Ital Dermatol Venereol; 1989 Mar; 124(3):97-102. PubMed ID: 2807392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoids in disorders of keratinization: their use in adults.
    Happle R; van de Kerkhof PC; Traupe H
    Dermatologica; 1987; 175 Suppl 1():107-24. PubMed ID: 2961628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma.
    Haftek M; Cambazard F; Dhouailly D; Réano A; Simon M; Lachaux A; Serre G; Claudy A; Schmitt D
    Br J Dermatol; 1996 Sep; 135(3):448-53. PubMed ID: 8949442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapeutic efficacy of tigazon in treating dermatoses].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Kriazheva SS; Butov IuS
    Vestn Dermatol Venerol; 1990; (5):4-6. PubMed ID: 2402940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
    Findlay GH
    S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of etretinate therapy in twins with severe congenital lamellar ichthyosis.
    Waisman Y; Rachmel A; Metzker A; Wielunsky E; Nitzan M; Rotem A; Steinherz R
    Pediatr Dermatol; 1989 Sep; 6(3):226-8. PubMed ID: 2798261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral retinoid (Ro 10-9359) in children with lamellar ichthyosis, epidermolytic hyperkeratosis and symmetrical progressive erythrokeratoderma.
    Tamayo L; Ruiz-Maldonado R
    Dermatologica; 1980; 161(5):305-14. PubMed ID: 6449393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comèl's ichthyosis linearis circumflexa: treatment with Ro 10-9359. Electron microscopic study].
    Mathys C; De Dobbeleer G; Ledoux M; Achten G
    Dermatologica; 1985; 171(4):283-90. PubMed ID: 4076500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.